AirMaster

CHINESE
中文 / EN
所有产品与服务 :
栏目 新闻 产品 人力

CHINA EXCELLENT HIGH-END CLEAN AIR CONDITIONING BRAND

As a large central air conditioning equipment manufacturer integrating research, development, production, sales and after-sale service, yasch air conditioning is a quality brand of special air conditioning for the domestic medical industry.
INDUSTRIAL LAYOUT
AirMaster has widespread brand recognition in fields of bio-pharmaceuticals, spray coatings for automobiles, foods, high-end electronic products, laboratories and tobaccos, and has country-wide sample projects. Market shares in medical purification field: 70%; in tobacco purification field: 50%; and in bio-pharmaceuticals: 40%.
View More

Energy-saving Solutions for Air-conditioning System of Hospital Operating Department

  • Condensed Heat Recovery-based Energy-saving Four-pipe Air-conditioning System
    The air handling form of such system is still primary return air system, also the standard four-pipe system, which uses the waste heat from condensing of the refrigerating system as heat source, thus to resolve the reheating energy consumption problem of air-conditioners in operating department in summer....
    Sanitary
    Comfortable
    Energy-saving
    Reliable

    Bacteria count and cleanness of indoor air meet the comprehensive requirements of the operating room, comfort is the most basic requirement, energy-saving operation is the enduring topic of clean air-conditioners, and only reliable air-conditioning system can guarantee the health of doctors and patients.

    View More

NEWS CENTER

Gather Real-time Events of Company, Issue the Latest AirMaster News and Industrial Information, and Welcome to Your Attention!
Understand AirMaster
Founded in Hongkong in 1981, AirMaster is the earliest national brand that enters the mainland purification air-conditioning field and is
China’s largest medical purification air conditioner manufacturer.
View More
  • 70%
    Market share of medical purification field
  • 50%
    Market share of tobacco purification field
  • 40%
    Market share of bio-pharmaceutical field